About Stellixir Biotech
Stellixir Biotech is a Healthcare company based in Bengaluru (India) by Janardhana PB. It provides in vitro disease modeling, drug discovery, and toxicology services. It operates on a B2B model. Its chief executive, as recorded, is Janardhana PB. Its Indian entity Stellixir Biotech Private Limited reported revenue of ₹51.6 Lakh. Stellixir Biotech offers products and services including In Vitro Disease Modelling, Toxicology and Safety Assessment, and Stem Cell Research Services. Its focus areas include Biotechnology, Stem Cell Research, Regenerative Medicine and Cell Line Engineering.
Company details
Stellixir Biotech Pvt. Ltd., based in Bangalore, India, is a preclinical contract research organization specializing in in vitro services for drug discovery, toxicology, and stem cell research. They deliver customized solutions for various diseases, including cardiovascular and oncology, using advanced facilities and regulatory-compliant methods. Serving biotech, pharma, and academic clients, they focus on innovative, reliable preclinical testing to support early drug development.
- Headquarters Bengaluru, India
- Founders Janardhana PB
- SectorsHealthcare
- Email••••••••
- Website stellixir.com
- Social LinkedIn X Facebook
- Legal Name Stellixir Biotech Private Limited
- Date of Incorporation 10 Sep, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹51.6 Lakh
FY 2024 · +34% YoY
- Net Loss-₹15.1 Lakh
FY 2024 · -29% margin
- EBITDA-₹1 Lakh
FY 2024 · -2% margin
Associated legal entities of Stellixir Biotech
Stellixir Biotech operates through Stellixir Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stellixir Biotech Private Limited CIN U74900KA2014PTC076297 | Active | 10 Sep 2014 | Bangalore, Karnataka | ₹0.5 Cr | 2 | View details |
Products & Services of Stellixir Biotech
Stellixir Biotech offers a comprehensive portfolio of products and services, including In Vitro Disease Modelling, Toxicology and Safety Assessment, and Stem Cell Research Services.
Customized services for early drug discovery using cell-based models.
Evaluates drug toxicity across various organ systems.
Offers isolation and characterization for degenerative disease studies.
Board of directors of Stellixir Biotech Private Limited (Stellixir Biotech)
Stellixir Biotech Private Limited is the primary company behind Stellixir Biotech. The board of Stellixir Biotech Private Limited currently have 2 directors; the longest-serving is Beedarekere Veerabhadregowda Ramegowda, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Beedarekere Veerabhadregowda Ramegowda DIN 06949472 | Director | 10 Sep 2014 | 12 yrs 1 mo | Stellixir Biotech Private Limited |
| Papayya Balakrishna Janardhana DIN 06949975 | Director | 10 Sep 2014 | 12 yrs 1 mo | Stellixir Biotech Private Limited |
People of Stellixir Biotech
1 people are tracked at Stellixir Biotech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Janardhana PB | Founder, CEO | Leadership |
Complete people profiles for Stellixir Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Stellixir Biotech
Figures of Stellixir Biotech Private Limited, the primary company behind Stellixir Biotech, for FY 2024. Revenue was ₹51.6 Lakh (+34% year on year). Net loss was -₹15.1 Lakh (-29% margin). EBITDA was -₹1 Lakh (-2% margin). Revenue has grown at a compounded annual rate of +23% over three years and 0% over five years.
- ₹51.6 LakhRevenue · FY 2024 · +34% YoY
- -₹15.1 LakhNet loss · -29% margin
- -₹1 LakhEBITDA · -2% margin
- ₹5 LakhPaid-up capital
- +23%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Stellixir Biotech Private Limited are on its company page.
Detailed financial statements for Stellixir Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Stellixir Biotech
Websites that share an audience with Stellixir Biotech (stellixir.com).
Websites whose visitors overlap most with Stellixir Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cellkraft.in | cellkraft.in | 100% | #12,215,661 | – | |
credora.in | credora.in | 100% | #14,435,851 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stellixir Biotech
Stellixir Biotech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Janardhana PB is the CEO of Stellixir Biotech, as recorded in our data. They have also founded this company.
The primary company behind Stellixir Biotech, Stellixir Biotech Private Limited, reported revenue of ₹51.6 Lakh for FY 2024, up 34% year on year.
Stellixir Biotech Pvt. Ltd., based in Bangalore, India, is a preclinical contract research organization specializing in in vitro services for drug discovery, toxicology, and stem cell research. They deliver customized solutions for various diseases, including cardiovascular and oncology, using advanced facilities and regulatory-compliant methods. Serving biotech, pharma, and academic clients, they focus on innovative, reliable preclinical testing to support early drug development.
Stellixir Biotech offers In Vitro Disease Modelling, Toxicology and Safety Assessment, and Stem Cell Research Services.
Stellixir Biotech operates through Stellixir Biotech Private Limited.
The legal entities of Stellixir Biotech currently have 2 directors, including Beedarekere Veerabhadregowda Ramegowda, Papayya Balakrishna Janardhana.